PO10-TU-32 The Rebif new formulation versus Betaseron tolerability study: twelve week comparative phase findings
| Autor: | Singer, B., Jeffery, D., Kirzinger, S., Bennett, R., AL-Sabbagh, A., Dangond, F. |
|---|---|
| Zdroj: | In Journal of the Neurological Sciences 2009 285 Supplement 1:S204-S204 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect